ValenTx is developing a revolutionary new therapy to treat patients with obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. The technology mimics the therapeutic mechanisms of a Roux-en-Y gastric bypass, and does this with a non-surgical, endoluminal bypass device.